2022/02/07
After a torrid 2021, auspicious signs released from the policymakers for investors, are emerging that the bad narrative surrounding the Chinese equity market is shifting to the good. The four major A-share indexes opened higher on the first trading day of the Year of the Tiger. The Shanghai Composite Index rose above 3,400 points and closed up 2%, while the ChiNext Index softened after nearly 3,000 points. Turnover in the two cities edged up to 820 billion (RMB).
Before the holiday, the northbound funds of Shanghai and Shenzhen Stock Connect recorded a net sale, and the financing balance of the two markets also decreased. After the holiday, the northbound funds bought a net 5.5 billion (RMB). Although the Year of the Tiger may not prove to be as terrible for investors as its predecessor, it is not easy for investors to transit into a “hope” phase from “despair.”
Six new shares will begin to subscribe in the first week of the Year of the Tiger, including the domestic flu vaccine leader Hualan Vaccine (301207.SZ). Hillhouse Huaying, in which Tencent and Hillhouse teamed up to invest, was one of the war investors and holds 9% of the shares of Hualan Vaccine.
內地政策釋放利好訊號，帶動A股四大指數，在虎年首個交易日齊齊高開。上證指數重上3,400點以上，收市升百分之2，創業板指數則升近3,000點後回軟，曾經倒跌，收市靠穩。兩市成交額微升至8,200億元人民幣。假期前，滬深股通北向資金錄得淨賣出，兩市融資餘額亦見減少，假期後，北向資金淨買入55億元人民幣，分析認為，雖然紅盤高收，但成交未算配合，反映市場仍然審慎。
另外，虎年首周將會迎來六隻新股開始認購，包括生產流感疫苗的華蘭疫苗。騰訊和高瓴有份投資的高瓴驊盈，一共持有華蘭疫苗百分之九的股份。
Comments